|Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran|
AA Velayati, MR Masjedi, P Farnia, P Tabarsi, J Ghanavi, AH ZiaZarifi, ...
Chest 136 (2), 420-425, 2009
|Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients|
SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ...
PLoS medicine 9 (8), 2012
|Diabetes mellitus and tuberculosis facts and controversies|
P Baghaei, M Marjani, P Javanmard, P Tabarsi, MR Masjedi
Journal of Diabetes & Metabolic Disorders 12 (1), 58, 2013
|Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first-and second-line drugs: an …|
ML Bastos, H Hussain, K Weyer, L Garcia-Garcia, V Leimane, CC Leung, ...
Clinical infectious diseases 59 (10), 1364-1374, 2014
|Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level|
AA Velayati, P Farnia, MR Masjedi, TA Ibrahim, P Tabarsi, RZ Haroun, ...
European Respiratory Journal 34 (5), 1202-1203, 2009
|Interaction of pattern recognition receptors with Mycobacterium tuberculosis|
E Mortaz, IM Adcock, P Tabarsi, MR Masjedi, D Mansouri, AA Velayati, ...
Journal of clinical immunology 35 (1), 1-10, 2015
|Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis|
TCG for the Meta, N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, ...
The Lancet 392 (10150), 821-834, 2018
|First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance|
M Shamaei, M Marjani, E Chitsaz, M Kazempour, M Esmaeili, P Farnia, ...
International Journal of Infectious Diseases 13 (5), e236-e240, 2009
|Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity|
S Baniasadi, P Eftekhari, P Tabarsi, F Fahimi, MR Raoufy, MR Masjedi, ...
European journal of gastroenterology & hepatology 22 (10), 1235-1238, 2010
|Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006|
MR Masjedi, P Tabarsi, E Chitsaz, P Baghaei, M Mirsaeidi, MV Amiri, ...
The International Journal of Tuberculosis and Lung Disease 12 (7), 750-755, 2008
|Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis|
MA Merza, P Farnia, P Tabarsi, M Khazampour, MR Masjedi, AA Velayati
The Journal of Infection in Developing Countries 5 (07), 511-519, 2011
|Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy|
AA Velayati, P Farnia, TA Ibrahim, RZ Haroun, HO Kuan, J Ghanavi, ...
Chemotherapy 55 (5), 303-307, 2009
|Inherited disorders of the IL-12-IFN-γ axis in patients with disseminated BCG infection|
D Mansouri, P Adimi, M Mirsaeidi, N Mansouri, S Khalilzadeh, ...
European journal of pediatrics 164 (12), 753-757, 2005
|ISG15 deficiency and increased viral resistance in humans but not mice|
SD Speer, Z Li, S Buta, B Payelle-Brogard, L Qian, F Vigant, E Rubino, ...
Nature communications 7 (1), 1-10, 2016
|Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases|
P Baghaei, P Tabarsi, E Chitsaz, M Saleh, M Marjani, S Shemirani, ...
American journal of therapeutics 17 (1), 17-22, 2010
|The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping|
MR Masjedi, M Varahram, M Mirsaeidi, M Ahmadi, M Khazampour, ...
BMC infectious diseases 8 (1), 109, 2008
|Cancers related to immunodeficiencies: update and perspectives|
E Mortaz, P Tabarsi, D Mansouri, A Khosravi, J Garssen, A Velayati, ...
Frontiers in immunology 7, 365, 2016
|Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran|
P Baghaei, P Tabarsi, D Dorriz, M Marjani, M Shamaei, MV Pooramiri, ...
American journal of therapeutics 18 (2), e29-e34, 2011
|Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran|
SM Mirsaeidi, P Tabarsi, K Khoshnood, MV Pooramiri, A Rowhani-Rahbar, ...
International journal of infectious diseases 9 (6), 317-322, 2005
|Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: an individual patient data metaanalysis|
GJ Fox, CD Mitnick, A Benedetti, ED Chan, M Becerra, CY Chiang, ...
Clinical Infectious Diseases 62 (7), 887-895, 2016